Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2022-06-09 00:00:00 ET · period of report 2022-06-07 · accession 0001127602-22-017163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-09 | 2022-06-07 | BCRX | Hutson Nancy J | Dir | A - Grant | $0.00 | +12.9K | 77.9K | +20% | $0 |
| D | 2022-06-09 | 2022-06-07 | BCRX | Hutson Nancy J | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-07 | A | A | 12,866 | $0.00 | 77,939 | D | — | — | (F1) Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant. |
| 2 | Derivative | Automatic Stock Option Grant | 2022-06-07 | A | A | 30,022 | $0.00 | 30,022 | D | $10.79 · 2023-06-07 to 2032-06-07 | 30,022 Common Stock | (F2) Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy. |